Prolactin may be increased in newly diagnosed celiac children and adolescents and decreases after 6 months of gluten-free diet

Hormone Research in Paediatrics

Volumn 81, Issue 5, 2014, Pages 309-313

  Delvecchio, Maurizio ^a   Faienza, Maria Felicia ^b   Lonero, Antonella ^b   Rutigliano, Vincenzo ^b   Francavilla, Ruggiero ^b   Cavallo, Luciano ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Autoimmunity; Celiac disease; Childhood; Gluten free diet; Prolactin

Indexed keywords

PROLACTIN; CYTOKINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; FEMALE; GLUTEN FREE DIET; HUMAN; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROLACTIN RELEASE; RISK FACTOR; ADOLESCENT; AGE; BLOOD; CLINICAL TRIAL; COMPLICATION; DIET THERAPY; PRESCHOOL CHILD; TIME; ADOLESCENT DISEASE; CHILDHOOD DISEASE; HORMONE RELEASE; PREVALENCE;

ADOLESCENT; AGE FACTORS; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; CYTOKINES; DIET, GLUTEN-FREE; FEMALE; HUMANS; HYPERPROLACTINEMIA; MALE; PROLACTIN; TIME FACTORS;

EID: 84902543629     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000357064     Document Type: Article

References (39)

1. Gujral N, Freeman HJ, Thomson AB: Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 2012; 18: 6036-6059.
2. Rewers M: Epidemiology of celiac disease: what are the prevalence, incidence and progression of celiac disease? Gastroenterology 2005; 128(4 suppl 1):S47-S51. (Pubitemid 40460821)
3. Sollid LM: Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002; 2: 647-655.
4. Kagnoff MF: Overview and pathogenesis of celiac disease. Gastroenterology 2005; 128: 10-18.
5. Di Sabatino A, Corazza GR: Coeliac disease. Lancet 2009; 373: 1480-1493.
6. Cianci R, Cammarota G, Frisullo G: Tissueinfiltrating lymphocytes analysis reveals large modifications of the duodenal immunological niche in coeliac disease after gluten-free diet. Clin Transl Gastroenterol 2012; 3:e28.
7. Dieterich W, Ehnis T, Bauer M: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801.
8. Collin P, Kaukinen K, Välimäki M: Endocrinological disorders and celiac disease. Endocr Rev 2002; 23: 464-483.
9. Bodd M, Raki M, Tollefsen S, Fallang LE, Bergseng E, Lundin KE, Sollid LM: HLADQ2- restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol 2010; 3: 594-601.
10. Collin P, Hakanen M, Salmi J, Maki M, Kaukinen K: Autoimmune hypopituitarism in patients with coeliac disease: symptoms confusingly similar. Scand J Gastroenterol 2001; 36: 558-560.
11. Giovenale D, Meazza C, Cardinale GM, Sposito M, Mastrangelo C, Messini B, Citro G, Delvecchio M, Di Maio S, Bozzola M: The prevalence of growth hormone deficiency and celiac disease in short children. Clin Med Res 2006; 4: 180-183.
12. Delvecchio M, De Bellis A, Francavilla R, Rutigliano V, Predieri B, Indrio F, De Venuto D, Sinisi AA, Bizzarro A, Bellastella A, Iughetti L, Cavallo L; Italian Autoimmune Hypophysitis Network Study: Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to lineargrowth impairment. Am J Gastroenterol 2010; 105: 691-696.
13. Horseman ND: Basic physiology: prolactin; in De Groot LJ, Jameson JL (eds): Endocrinology, ed 4. Philadelphia, Saunders, 2001, pp 209-220.
14. De Bellis A, Bizzarro A, Pivoncello R: Prolactin and autoimmunity. Pituitary 2005; 8: 25-30.
15. Chikanza IC: Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann NY Acad Sci 1999; 876: 119-123.
16. Reifen R, Briskila D, Maislas M: Serum prolactin in celiac disease: a marker for disease activity. Arch Dis Child 1997; 77: 155-157.
17. Kapur G, Patwari AK, Narayan S: Serum prolactin in celiac disease. J Trop Pediatr 2004; 50: 37-40.
18. Varkonyi A, Boda M, Endreffy E: Coeliac disease: always something to discover. Scand J Gastroenterol Suppl 1998; 228: 122-129.
19. Gocyla U, Szczepanski Z, Kalita B: Serum prolactin concentration in children with celiac disease. Pediatr Pol 1996; 71: 797-800.
20. Fanciulli G, Tomasi PA, Delitalia G: Serum prolactin in celiac schoolchildren. Arch Dis Child 2003; 88: 945-946.
21. Theintz GE, Nusslè D, Cox J: Prolactin and the gut: a controversy. J Pediatr Gatroenterol Nutr 1984; 3: 523-528.
22. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A: Italian cross-sectional growth charts for height, weight and BMI (2 to 20 years). J Endocrinol Invest 2006; 29: 581-593.
23. Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J: Prolactin in human systemic lupus erythematosus. Lupus 2001; 10: 748-756.
24. Chikanza IC, Petrou P, Chrousos G, Kingsley G, Panayi GS: Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications. Br J Rheumatol 1993; 32: 445-448.
25. El Miedany YM, Ahmed I, Moustafa H, El Baddini M: Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation? Joint Bone Spine 2004; 71: 203-208.
26. Neidhart M: Prolactin in autoimmune diseases. Proc Soc Exp Biol Med 1998; 217: 408-419.
27. Li J, Teng W, Shan Z: Effects of prolactin on HLA-DR and CD40 expressions by human thyrocytes. Chin Med J 2001; 114: 1151-1156.
28. Giusti M, Foppiani L, Fazzuoli L, Molinari E, Guido R, Valenti S, Giordano G: An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs (in Italian). Recenti Prog Med 1999; 90: 147-151. (Pubitemid 29163141)
29. Lever EG, McKerron CG: Auto-immune Addison's disease associated with hyperprolactinaemia. Clin Endocrinol 1984; 21: 451-457.
30. Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S: Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 1995; 80: 2302-2311.
31. Azar ST, Yamout B: Prolactin secretion is increased in patients with multiple sclerosis. Endocr Res 1999; 25: 207-214.
32. Palová-Jelínková L, Dánová K, Drasarová H, Dvorák M, Funda DP, Fundová P, Kotrbová- Kozak A, Cerná M, Kamanová J, Martin SF, Freudenberg M, Tucková L: Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-kB signaling pathway and an NLRP3 inflammasome activation. PLoS One 2013; 8:e62426.
33. Harris KM, Fasano A, Mann DL: Cutting edge: IL-1 controls the IL-23 response induced by gliadin, the etiologic agent in celiac disease. J Immunol 2008; 181: 4457-4460.
34. Kapoor A, Patwari AK, Kumar P, Jain A, Narayan S: Serum soluble interleukin-2 receptor, interleukin-6 and tumor necrosis factor alpha as markers of celiac disease activity. Indian J Pediatr 2013; 80: 108-113.
35. Bayardo M, Punzi F, Bondar C, Chopita N, Chirdo F: Transglutaminase 2 expression is enhanced synergistically by interferon-gamma and tumour necrosis factor-alpha in human small intestine. Clin Exp Immunol 2012; 168: 95-104.
36. Laparra Llopis JM, Sanz Herranz Y: Gliadins induce TNFalpha production through cAMPdependent protein kinase A activation in intestinal cells (Caco-2). J Physiol Biochem 2010; 66: 153-159.
37. Manavalan JS, Hernandez L, Shah JG, Konikkara J, Naiyer AJ, Lee AR, Ciaccio E, Minaya MT, Green PH, Bhagat G: Serum cytokine elevations in celiac disease: association with disease presentation. Hum Immunol 2010; 71: 50-57.
38. Street ME, Volta C, Ziveri MA, Zanacca C, Banchini G, Viani I, Rossi M, Virdis R, Bernasconi S: Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet. Clin Endocrinol 2008; 68: 22-28.
39. Matera L, Mori M: Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin- 12 on production of interferon gamma by natural killer and T cells. Ann NY Acad Sci 2000; 917: 505-511.